Prospective and retrospective analysis of amyloidosis patients : Early diagnosis and prognosis factor of amyloidosis

Korea Centers for Disease Control and Prevention0 个研究点目标入组 80 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•Inclusion criteria
•1) Patients were histologically verified amyloidosis deposition at least one or more organ
•Or Patients were reasonable to be diagnosed a cardiac amyloidosis on echocardiography or heart magnetic resonance imaging increasing with immunoglobulin light chain in serum or urine.
•- Echocardiography results: mean left ventricular wall thickness >12mm and patients who have no other cardiovascular disease such as valve disease or hypertension
•- Heart magnetic resonance imaging results:
•Gadolinium delayed enhancement in a wide range of endocardium
•2) Patients who were aged 20 years or older
•3) Patients who were obtained consent form to participate the research
•4) Patients who were written consent form to genetic and biochemical test for research purpose using bone marrow, peripheral blood and tissue obtained for diagnostic purpose

•Exclusion criteria
•Patients who do not agree with this study and biochemical and genetic examination

发起方

Korea Centers for Disease Control and Prevention